Bonnie H. Anderson

This profile gathers the share dealings of Bonnie H. Anderson across 3 companies, led by Veracyte, Inc., Castle Biosciences Inc and Bruker Corp. In total, 210 filings cover trades dated from 2 May 2014 to 15 February 2026.

On the open market, the record shows 4 purchases worth €49k and 82 sales worth €24.6M. The net balance comes to €24.6M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 35 share grants and 77 option exercises.

The median purchase comes to €12k. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 4 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +3.2%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 18 February 2026, reports a share grant in Bruker Corp. The most recent open-market purchase was published on 3 June 2016, 3,810 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.